Affinity maturation
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
In immunology, affinity maturation is the process by which T FH cell-activated B cells produce antibodies with increased affinity for antigen during the course of an immune response. With repeated exposures to the same antigen, a host will produce antibodies of successively greater affinities. A secondary response can elicit antibodies with several fold greater affinity than in a primary response. Affinity maturation primarily occurs on membrane immunoglobulin of germinal center B cells and as a direct result of somatic hypermutation (SHM) and selection by T FH cells. Affinity maturation also occurs when GC B cells encounter antigens related to the original antigen they were raised against, as long as some binding capabilities remain against the new variant antigen. Over many rounds of maturation against new variants, GC B cells could (very rarely) end up producing broadly-neutralizing antibodies that bind the common (conserved) part of these antigens. One ideal in the field of vaccination is to reliably replicate this process so as to immunize against a broad spectrum of related pathogens. __TOC__
In immunology, affinity maturation is the process by which T FH cell-activated B cells produce antibodies with increased affinity for antigen during the course of an immune response. With repeated exposures to the same antigen, a host will produce antibodies of successively greater affinities. A secondary response can elicit antibodies with several fold greater affinity than in a primary response. Affinity maturation primarily occurs on membrane immunoglobulin of germinal center B cells and as a direct result of somatic hypermutation (SHM) and selection by T FH cells. Affinity maturation also occurs when GC B cells encounter antigens related to the original antigen they were raised against, as long as some binding capabilities remain against the new variant antigen. Over many rounds of maturation against new variants, GC B cells could (very rarely) end up producing broadly-neutralizing antibodies that bind the common (conserved) part of these antigens. One ideal in the field of vaccination is to reliably replicate this process so as to immunize against a broad spectrum of related pathogens. __TOC__
Text derived from https://en.wikipedia.org/w/index.php?oldid=1369776965 under CC BY-SA 4.0; modifications have been made.